Ivan Maillard
Overview
Explore the profile of Ivan Maillard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
6352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Gimotty P, Matthews A, Mamtani R, Luger S, Hexner E, et al.
Blood Adv
. 2025 Jan;
9(3):533-544.
PMID: 39888631
Little is known about the impact of recent advances in acute myeloid leukemia (AML) treatment on racial/ethnic disparities in survival outcomes. We performed a retrospective cohort study of patients with...
2.
Allman A, Gaudette B, Kelly S, Alouche N, Carrington L, Perkey E, et al.
Immunity
. 2024 Dec;
58(1):143-161.e8.
PMID: 39731910
Innate-like splenic marginal zone (MZ) B (MZB) cells play unique roles in immunity due to their rapid responsiveness to blood-borne microbes. How MZB cells integrate cell-extrinsic and -intrinsic processes to...
3.
Rowe M, Babushok D, Carroll M, Carulli A, Frey N, Gill S, et al.
Eur J Haematol
. 2024 Dec;
114(4):626-635.
PMID: 39726154
Venetoclax with hypomethylating agents (HMA) is the standard of care for acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy and is associated with tumor lysis syndrome (TLS). TLS...
4.
Bettini E, Chudnovskiy A, Protti G, Nakadakari-Higa S, Ceglia S, Castano D, et al.
bioRxiv
. 2024 May;
PMID: 38798523
Nucleoside-modified mRNA vaccines elicit protective antibodies through their ability to promote T follicular helper (Tfh) cells. The lipid nanoparticle (LNP) component of mRNA vaccines possesses inherent adjuvant activity. However, to...
5.
Bandyopadhyay S, Duffy M, Ahn K, Sussman J, Pang M, Smith D, et al.
Cell
. 2024 May;
187(12):3120-3140.e29.
PMID: 38714197
Non-hematopoietic cells are essential contributors to hematopoiesis. However, heterogeneity and spatial organization of these cells in human bone marrow remain largely uncharacterized. We used single-cell RNA sequencing (scRNA-seq) to profile...
6.
Liu Y, Li Q, Song L, Gong C, Tang S, Budinich K, et al.
Cancer Discov
. 2024 Apr;
14(8):1522-1546.
PMID: 38655899
Gain-of-function mutations in the histone acetylation "reader" eleven-nineteen-leukemia (ENL), found in acute myeloid leukemia (AML) and Wilms tumor, are known to drive condensate formation and gene activation in cellular systems....
7.
Bandyopadhyay S, Duffy M, Ahn K, Pang M, Smith D, Duncan G, et al.
bioRxiv
. 2024 Apr;
PMID: 38559168
The bone marrow is the organ responsible for blood production. Diverse non-hematopoietic cells contribute essentially to hematopoiesis. However, these cells and their spatial organization remain largely uncharacterized as they have...
8.
Schneider M, Allman A, Maillard I
Curr Opin Cell Biol
. 2023 Oct;
85:102256.
PMID: 37806295
In multicellular organisms, cell-to-cell communication is critical for the regulation of tissue organization. Notch signaling relies on direct interactions between Notch receptors on signal-receiving cells and Notch ligands on adjacent...
9.
Goldman N, Chandra A, Johnson I, Sullivan M, Patil A, Vanderbeck A, et al.
Nat Immunol
. 2023 Aug;
24(10):1698-1710.
PMID: 37592014
In development, pioneer transcription factors access silent chromatin to reveal lineage-specific gene programs. The structured DNA-binding domains of pioneer factors have been well characterized, but whether and how intrinsically disordered...
10.
Brandstadter J, Outen R, Maillard I
J Clin Invest
. 2023 Aug;
133(15).
PMID: 37526083
Allogeneic hematopoietic cell transplantation can cure patients with high-risk leukemia through graft-versus-leukemia (GVL) effects, the process by which malignant leukemic cells are cleared by donor-derived immune cells from the graft....